GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » ROE % Adjusted to Book Value

Acepodia (ROCO:6976) ROE % Adjusted to Book Value : -2.53% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia ROE % Adjusted to Book Value?

Acepodia's ROE % for the quarter that ended in Jun. 2024 was -5.57%. Acepodia's PB Ratio for the quarter that ended in Jun. 2024 was 2.20. Acepodia's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -2.53%.

Acepodia ROE % Adjusted to Book Value Historical Data

The historical data trend for Acepodia's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia ROE % Adjusted to Book Value Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - -15.81

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Negative Equity - - -2.01 -2.53

Competitive Comparison of Acepodia's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Acepodia's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acepodia's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Acepodia's ROE % Adjusted to Book Value falls into.


Acepodia ROE % Adjusted to Book Value Calculation

Acepodia's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-47.75% / 3.02
=-15.81%

Acepodia's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.57% / 2.20
=-2.53%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acepodia ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Acepodia's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
ROCO:4174 ROCO:6617 ROCO:4162 ROCO:6712 ROCO:4147 ROCO:6586 ROCO:6547 ROCO:6919 TPE:4142 ROCO:4157 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Website
https://www.acepodia.com
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines